KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Nelonemdaz for Patients With Acute Ischemic Stroke Undergoing Endovascular Reperfusion Therapy: A Randomized Phase II Trial.StrokePMID 36065810PMC95868312022-Nov0.98未发现恶性肿瘤人群证据。待处理
Survival with novel hormonal therapies in patients with nonmetastatic castration-resistant prostate cancer: indirect comparison of three randomized phase-III trials.World J UrolPMID 36083316无 PMCID2022-Nov0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: Analysis of Safety and Efficacy for Patients With Renal Impairment.Clin Lung CancerPMID 36114096无 PMCID2022-Nov0.70While the study meets criteria for oncology, human, randomized, Phase 3, drug intervention, and original result, the abstract does not explicitly present a primary time-to-event efficacy endpoint (like OS or PFS with KM or HR) for the main trial population. The reported efficacy comparison is described generally ('difference in treatment efficacy... was similar to that among the overall study population'), but the specific endpoint and its time-to-event nature are not confirmed. Therefore, eligibility cannot be fully established.待处理
Safety Findings in Lasmiditan as a Novel Acute Treatment of Migraine in Chinese Patients: A Post Hoc Analysis of the Randomized Controlled Phase 3 CENTURION Trial.Adv TherPMID 36114949无 PMCID2022-Nov0.98未发现恶性肿瘤人群证据。待处理
Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Aspart (MYL-1601D) Compared with Originator Insulin Aspart (Novolog®) in Patients with Type 1 Diabetes After 24 Weeks: A Randomized Open-Label Study.BioDrugsPMID 36114990PMC96494812022-Nov0.98未发现恶性肿瘤人群证据。待处理
A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis.Int ImmunopharmacolPMID 36126411无 PMCID2022-Nov0.98未发现恶性肿瘤人群证据。待处理
Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer.Oral OncolPMID 36126605无 PMCID2022-Nov0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
The obesity paradox: Retinopathy, obesity, and circulating risk markers in youth with type 2 diabetes in the TODAY Study.J Diabetes ComplicationsPMID 36150365PMC123962722022-Nov0.90The record describes a non-oncology clinical trial (TODAY Study) focused on type 2 diabetes and diabetic retinopathy in adolescents. Although it is a randomized, Phase III study in humans, the subject matter and outcomes are not relevant to oncology Kaplan-Meier digitization.待处理
Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial.Lancet Diabetes EndocrinolPMID 36152639无 PMCID2022-Nov0.98未发现恶性肿瘤人群证据。待处理
The efficacy and safety of DW1601 in patients with acute bronchitis: a multi-center, randomized, double-blind, phase III clinical trial.Korean J Intern MedPMID 36153858PMC96662452022-Nov0.98未发现恶性肿瘤人群证据。待处理
Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Trial.BioDrugsPMID 36169807PMC96495132022-Nov0.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
A cross-sectional study of participant recruitment rates in published phase III influenza therapeutic randomized controlled trials conducted in the clinical setting.Am J Emerg MedPMID 36174486无 PMCID2022-Nov0.98未发现恶性肿瘤人群证据。待处理
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.Lancet OncolPMID 36183733无 PMCID2022-Nov0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma: Health-related quality of life from the randomized phase 3 KEYNOTE-716 study.Eur J CancerPMID 36202690无 PMCID2022-Nov0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial.Lancet OncolPMID 36265502无 PMCID2022-Nov0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study.Lancet OncolPMID 36265504无 PMCID2022-Nov0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.Lancet HaematolPMID 36328040无 PMCID2022-Nov0.85The trial is a phase 3 RCT with drug intervention, but the primary efficacy endpoint (MRD negativity) is not a time-to-event endpoint, and no time-to-event primary/key secondary endpoint is reported in the provided abstract.待处理
The XINDI Study: A Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Safinamide as Add-On Therapy to Levodopa in Chinese Patients with Parkinson's Disease with Motor Fluctuations.CNS DrugsPMID 36346534PMC96413002022-Nov0.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of Tregopil, a novel, ultra-rapid acting oral prandial insulin analog, as part of a basal-bolus regimen in type 2 diabetes: a randomized, active-controlled phase 2/3 study.Expert Opin PharmacotherPMID 36352762无 PMCID2022-Nov0.98未发现恶性肿瘤人群证据。待处理
Bilateral Effect of OC-01 (Varenicline Solution) Nasal Spray for Treatment of Signs and Symptoms in Individuals with Mild, Moderate, and Severe Dry Eye Disease.Clin TherPMID 36763994无 PMCID2022-Nov0.98未发现恶性肿瘤人群证据。待处理
A Preliminary Analysis on the Feasibility and Short-Term Efficacy of a Phase-III RCT on Mindfulness Added to Treatment as Usual for Patients with Chronic Migraine and Medication Overuse Headache.Int J Environ Res Public HealthPMID 36360996PMC96536202022-Oct-290.98未发现恶性肿瘤人群证据。待处理
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.LancetPMID 36522207无 PMCID2022-Oct-290.96主要研究目的为安全性/毒性或卫生经济学,未见合格 time-to-event 疗效终点。待处理
9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in South Korea.LancetPMID 36522208无 PMCID2022-Oct-290.98未发现恶性肿瘤人群证据。待处理
Mortality after multivessel revascularisation involving the proximal left anterior descending artery.HeartPMID 35732441PMC96269172022-Oct-280.98未发现恶性肿瘤人群证据。待处理
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy.BloodPMID 35917453PMC106530092022-Oct-270.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
VoiceS: voice quality after transoral CO2 laser surgery versus single vocal cord irradiation for unilateral stage 0 and I glottic larynx cancer-a randomized phase III trial.TrialsPMID 36303192PMC96152452022-Oct-270.95The study is a randomized phase III trial in human laryngeal cancer, but it lacks a drug-containing intervention (comparing radiotherapy vs. surgery) and its primary endpoint is a patient-reported voice quality outcome, not a time-to-event efficacy endpoint (OS, PFS, DFS, etc.). The abstract describes the study protocol, not final results.待处理
Immunogenicity and safety of high-dose quadrivalent influenza vaccine in older adults in Taiwan: A phase III, randomized, multi-center study.VaccinePMID 36216650无 PMCID2022-Oct-260.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trial.J Hematol OncolPMID 36289532PMC95980302022-Oct-260.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Monofilament suture versus braided suture thread to improve pregnancy outcomes after vaginal cervical cerclage (C-STICH): a pragmatic randomised, controlled, phase 3, superiority trial.LancetPMID 36273481无 PMCID2022-Oct-220.98未发现恶性肿瘤人群证据。待处理
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo.N Engl J MedPMID 36260792无 PMCID2022-Oct-200.98未发现恶性肿瘤人群证据。待处理
A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN).VaccinePMID 36150974无 PMCID2022-Oct-190.98未发现恶性肿瘤人群证据。待处理
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial.Int J CancerPMID 35583992无 PMCID2022-Oct-150.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Use of mobile data collection systems within large-scale epidemiological field trials: findings and lessons-learned from a vector control trial in Iquitos, Peru.BMC Public HealthPMID 36243698PMC95714642022-Oct-150.98未发现恶性肿瘤人群证据。待处理
A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630.Clin Cancer ResPMID 35980349PMC95616042022-Oct-140.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.ElifePMID 36226829PMC95961642022-Oct-130.98未发现恶性肿瘤人群证据。待处理
AmBisome Monotherapy and Combination AmBisome-Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial.Clin Infect DisPMID 35147680PMC95558382022-Oct-120.98未发现恶性肿瘤人群证据。待处理
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer.J Clin OncolPMID 35452273无 PMCID2022-Oct-100.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
Final Analysis of 3 Versus 6 Months of Adjuvant Oxaliplatin and Fluoropyrimidine-Based Therapy in Patients With Stage III Colon Cancer: The Randomized Phase III ACHIEVE Trial.J Clin OncolPMID 35512259无 PMCID2022-Oct-101.00命中用户提供的消化道肿瘤阳性参考集。待处理
Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.J Clin OncolPMID 36027558无 PMCID2022-Oct-100.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理
Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab-paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031).Jpn J Clin OncolPMID 35750038PMC95387552022-Oct-060.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
A phase III clinical trial evaluating efficacy and safety of minimal residual disease-based risk stratification for children with acute myeloid leukemia, incorporating a randomized study of gemtuzumab ozogamicin in combination with post-induction chemotherapy for non-low-risk patients (JPLSG-AML-20).Jpn J Clin OncolPMID 35809896无 PMCID2022-Oct-060.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or C.World J Clin CasesPMID 36246814PMC95615702022-Oct-060.98未发现恶性肿瘤人群证据。待处理
Five-year results of Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation.Eur J Cardiothorac SurgPMID 35348642PMC96154342022-Oct-040.98未发现恶性肿瘤人群证据。待处理
Custodiol-N versus Custodiol: a prospective randomized double-blind multicentre phase III trial in patients undergoing elective coronary bypass surgery.Eur J Cardiothorac SurgPMID 35579350无 PMCID2022-Oct-040.98未发现恶性肿瘤人群证据。待处理
Effect of Cefepime/Enmetazobactam vs Piperacillin/Tazobactam on Clinical Cure and Microbiological Eradication in Patients With Complicated Urinary Tract Infection or Acute Pyelonephritis: A Randomized Clinical Trial.JAMAPMID 36194218PMC95331862022-Oct-040.98未发现恶性肿瘤人群证据。待处理
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study).Clin Cancer ResPMID 35929990PMC95275032022-Oct-030.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial.J Clin PsychiatryPMID 36198061无 PMCID2022-Oct-030.98未发现恶性肿瘤人群证据。待处理
Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis.JAMA Netw OpenPMID 36287567PMC96068452022-Oct-030.98未发现恶性肿瘤人群证据。待处理
Weight-Based Compared With Fixed-Dose Enoxaparin Prophylaxis After Cesarean Delivery: A Randomized Controlled Trial.Obstet GynecolPMID 36075079PMC104732412022-Oct-010.98未发现恶性肿瘤人群证据。待处理
Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma.HaematologicaPMID 35354247PMC95212402022-Oct-010.96明确的 Phase III/IIIb/II-III 随机肿瘤药物试验,且报告 time-to-event 结局。待处理